Nathaniel David

Nathaniel David is an American scientist and biotechnology entrepreneur who has co-founded several life sciences companies that together have raised more than $1.5 billion in financing and contributed to the development of multiple FDA-approved medicines, including alogliptin, trelagliptin, Zemiglo (Zemdi), Zemdri, and Kybella.

Nathaniel David
Born	San Francisco, California, U.S.
Nationality	American
Alma mater	Harvard University, University of California, Berkeley
Known for	Kythera Biopharmaceuticals, Kybella, Jupiter Bioventures
Awards	MIT Technology Review Young Innovators Under 35
Scientific career
Fields	Biotechnology
Institutions	Kythera Biopharmaceuticals, Unity Biotechnology, Jupiter Bioventures